Literature DB >> 29552108

miR-106b promotes cell invasion and metastasis via PTEN mediated EMT in ESCC.

Jianxiang Zhang1, Danjie Chen2, Shuying Liang2, Jun Wang2, Can Liu2, Caiping Nie2, Zhengzheng Shan2, Liuxing Wang2, Qinxia Fan2, Feng Wang2.   

Abstract

MicroRNA (miR)-106b serves an essential function in a variety of human cancer types, particularly in the process of invasion and metastasis. However, the function and mechanism of miR-106b in the invasion and metastasis of esophageal squamous cell carcinoma (ESCC) has remained elusive. In the present study, it was demonstrated that miR-106b was upregulated in ESCC tissues and cell lines. Furthermore, miR-106b expression in ESCC tissues was positively associated with lymphatic metastasis. Inhibition of miR-106b in EC-1 and EC9706 cells decreased not only the invasion and metastasis ability but also the proliferation ability of EC-1 and EC9706 cells. In addition, miR-106b had the ability to induce epithelial-to-mesenchymal transition (EMT) in EC-1 and EC9706 cells. In terms of the underlying mechanism, it was revealed that miR-106b promoted the invasion, metastasis and proliferation ability of EC-1 and EC9706 cells by directly targeting phosphatase and tension homolog (PTEN). Furthermore, miR-106b induced EMT in EC-1 and EC9706 cells by suppressing the expression of PTEN. In summary, the present study revealed that miR-106b contributed to invasion and metastasis in ESCC by regulating PTEN mediated EMT. Downregulation of miR-106b may be a novel strategy for preventing tumor invasion and metastasis.

Entities:  

Keywords:  epithelial-to-mesenchymal transition; esophageal squamous cell carcinoma; invasion and metastasis; microRNA-106b; phosphatase and tensin homolog

Year:  2018        PMID: 29552108      PMCID: PMC5840519          DOI: 10.3892/ol.2018.7861

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  34 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  The Akt-associated microRNAs.

Authors:  Min Xu; Yin-Yuan Mo
Journal:  Cell Mol Life Sci       Date:  2012-08-31       Impact factor: 9.261

3.  PTEN Tumor Suppressor Network in PI3K-Akt Pathway Control.

Authors:  Maria-Magdalena Georgescu
Journal:  Genes Cancer       Date:  2010-12

Review 4.  The PTEN-AKT3 signaling cascade as a therapeutic target in melanoma.

Authors:  Subbarao V Madhunapantula; Gavin P Robertson
Journal:  Pigment Cell Melanoma Res       Date:  2009-05-28       Impact factor: 4.693

5.  MicroRNA-106b-25 cluster expression is associated with early disease recurrence and targets caspase-7 and focal adhesion in human prostate cancer.

Authors:  R S Hudson; M Yi; D Esposito; S A Glynn; A M Starks; Y Yang; A J Schetter; S K Watkins; A A Hurwitz; T H Dorsey; R M Stephens; C M Croce; S Ambs
Journal:  Oncogene       Date:  2012-09-17       Impact factor: 9.867

Review 6.  Dysregulation of non-coding RNAs in gastric cancer.

Authors:  Qing Yang; Ren-Wen Zhang; Peng-Cheng Sui; Hai-Tao He; Lei Ding
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

7.  MicroRNA-92a promotes growth, metastasis, and chemoresistance in non-small cell lung cancer cells by targeting PTEN.

Authors:  Ping Ren; Fangchao Gong; Yan Zhang; Jindong Jiang; Hong Zhang
Journal:  Tumour Biol       Date:  2015-10-02

8.  Astragalus saponins affect proliferation, invasion and apoptosis of gastric cancer BGC-823 cells.

Authors:  Tao Wang; Xiaoyan Xuan; Min Li; Ping Gao; Yuling Zheng; Wenqiao Zang; Guoqiang Zhao
Journal:  Diagn Pathol       Date:  2013-10-24       Impact factor: 2.644

9.  miR-655 Is an EMT-suppressive microRNA targeting ZEB1 and TGFBR2.

Authors:  Yosuke Harazono; Tomoki Muramatsu; Hironori Endo; Narikazu Uzawa; Tatsuyuki Kawano; Kiyoshi Harada; Johji Inazawa; Ken-ichi Kozaki
Journal:  PLoS One       Date:  2013-05-14       Impact factor: 3.240

10.  Downregulation of miR-106b induced breast cancer cell invasion and motility in association with overexpression of matrix metalloproteinase 2.

Authors:  Xiaojian Ni; Tiansong Xia; Yingchun Zhao; Wenbin Zhou; Naping Wu; Xiaoan Liu; Qiang Ding; Xiaoming Zha; Jiahao Sha; Shui Wang
Journal:  Cancer Sci       Date:  2013-12-04       Impact factor: 6.716

View more
  14 in total

1.  ARID1A knockdown triggers epithelial-mesenchymal transition and carcinogenesis features of renal cells: role in renal cell carcinoma.

Authors:  Keerakarn Somsuan; Paleerath Peerapen; Wanida Boonmark; Sirikanya Plumworasawat; Ratirath Samol; Natthiya Sakulsak; Visith Thongboonkerd
Journal:  FASEB J       Date:  2019-08-21       Impact factor: 5.191

2.  MiR-106b-5p Promotes Malignant Behaviors of Cervical Squamous Cell Carcinoma Cells by Targeting TIMP2.

Authors:  Huier Sun; Xuejun Chen
Journal:  Reprod Sci       Date:  2021-11-12       Impact factor: 3.060

Review 3.  miR-106b as an emerging therapeutic target in cancer.

Authors:  Surendra Kumar Sagar
Journal:  Genes Dis       Date:  2021-02-12

4.  TGF-β1-Induced Upregulation of MALAT1 Promotes Kazakh's Esophageal Squamous Cell Carcinoma Invasion by EMT.

Authors:  Qing Liu; Shutao Zheng; Yumei Chen; Tao Liu; Xiujuan Han; Xiao Zhang; Tongxue Shen; Xiaomei Lu
Journal:  J Cancer       Date:  2020-10-04       Impact factor: 4.207

5.  Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.

Authors:  Weiyang Lou; Jing Chen; Bisha Ding; Danni Chen; Huilin Zheng; Donghai Jiang; Liang Xu; Chang Bao; Guoqiang Cao; Weimin Fan
Journal:  J Transl Med       Date:  2018-09-29       Impact factor: 5.531

Review 6.  Epithelial-Mesenchymal Plasticity in Organotropism Metastasis and Tumor Immune Escape.

Authors:  Xiang Nan; Jiang Wang; Haowen Nikola Liu; Stephen T C Wong; Hong Zhao
Journal:  J Clin Med       Date:  2019-05-25       Impact factor: 4.241

7.  MicroRNA‑106b functions as an oncogene and regulates tumor viability and metastasis by targeting LARP4B in prostate cancer.

Authors:  Weiqi Yin; Junfeng Chen; Guoyao Wang; Dongxu Zhang
Journal:  Mol Med Rep       Date:  2019-06-05       Impact factor: 2.952

8.  Incorporating MicroRNA into Molecular Phenotypes of Circulating Tumor Cells Enhances the Prognostic Accuracy for Patients with Metastatic Breast Cancer.

Authors:  Weige Tan; Gehao Liang; Xinhua Xie; Wenguo Jiang; Luyuan Tan; Andrew J Sanders; Zihao Liu; Yun Ling; Wenjing Zhong; Zhenluan Tian; Wanyi Lin; Chang Gong
Journal:  Oncologist       Date:  2019-07-12

9.  Downregulation of miR‑486‑5p in papillary thyroid carcinoma tissue: A study based on microarray and miRNA sequencing.

Authors:  Dong-Yue Wen; Deng-Hua Pan; Peng Lin; Qiu-Yan Mo; Yun-Peng Wei; Yi-Huan Luo; Gang Chen; Yun He; Jun-Qiang Chen; Hong Yang
Journal:  Mol Med Rep       Date:  2018-07-03       Impact factor: 2.952

Review 10.  Promising Antineoplastic Actions of Melatonin.

Authors:  Gaia Favero; Enrico Moretti; Francesca Bonomini; Russel J Reiter; Luigi Fabrizio Rodella; Rita Rezzani
Journal:  Front Pharmacol       Date:  2018-10-16       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.